Health Care Reform

Starting with the 2020 plan year, exchanges will have to display star ratings, which rate plans on how well they perform.

Mylan and Teva Pharmaceuticals have been at the center of probes into allegations that generic-drug companies coordinated with one another on setting prices.

The combined carrier would have about $8.4 billion in revenue and 2.4 million enrollees.

Companies' strategies to rein in health care spending historically have not amounted to much. Is it time to try something more drastic?

2020 will likely be the second year in a row with a net increase in the number of insurers participating and relatively modest premium increases.

The average potential cost of an out-of-network admission for ER visits nearly tripled over a six-year period, from $220 to $628.